Israel Englander Y M Abs Therapeutics, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 71,586 shares of YMAB stock, worth $580,562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,586
Previous 349,784
79.53%
Holding current value
$580,562
Previous $4.23 Million
77.78%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding YMAB
# of Institutions
106Shares Held
24.5MCall Options Held
40.3KPut Options Held
400-
Paradigm Biocapital Advisors LP New York, NY4.09MShares$33.1 Million1.93% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$23.8 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$17.8 Million2.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.04MShares$16.5 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$14.8 Million0.15% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $355M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...